Finance & markets · 06/11/20261 min read
Zylox-Tonbridge and GL Capital Announce Strategic Investment in LifeTech Scientific to Build a Leading Vascular and Structural Heart Intervention Platform
Summary
HANGZHOU, China, Nov. 6, 2026 — Zylox-Tonbridge Medical Technology Co., Ltd.
Original source language: PR Newswire UK — News ReleasesOpen original release →